+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 5Years - 12Years
All Genders
ID04693858

Enhancing the Capacity of School Nurses to Reduce Excessive Anxiety in Children an Efficacy Trial of the CALM Intervention

Led by UConn Health · Updated on 2024-12-09

218

Participants Needed

2

Research Sites

3 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Excessive anxiety is common among elementary school children and can seriously affect their academic, social, and behavioral functioning. This research aims to evaluate the effectiveness of a brief, school nurse-delivered program called Child Anxiety Learning Modules CALM compared to a relaxation-only program CALM-R and a waitlist control. The study also looks at the cost effectiveness of CALM and explores factors that might influence its impact on childrens anxiety and school outcomes. The study involves three groups children receiving the full CALM program, children receiving the CALM-R relaxation modules, and a waitlist group that waits eight weeks before starting treatment. Both CALM and CALM-R include five modules delivered over eight weeks by trained school nurses. The CALM program includes psychoeducation, relaxation training, exposure therapy, cognitive restructuring, and relapse prevention, while CALM-R focuses on relaxation skills like deep breathing and muscle relaxation. Participants will be assessed before treatment, after eight weeks, and again at a 12-month follow-up. Researchers will use various measures including anxiety symptom ratings, behavioral avoidance, school attendance, academic performance, and teacher and parent questionnaires to evaluate outcomes. The study also monitors safety and treatment adherence. The total participation involves these assessments and the intervention period, with long-term follow-up to understand lasting effects.

CONDITIONS

Brief Title

Efficacy Trial of the CALM Intervention

Who Can Participate

Age: 5Years - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between the ages of 5 and 12 years
  • Have elevated anxiety symptoms indicated by a total SCARED score of 15 or higher or a Clinician Severity Rating of 3 or higher on any anxiety diagnosis
  • Be fluent in English to provide informed consent and complete study measures
  • Be on a stable dose of pharmacological or psychotherapeutic treatment for at least 4 weeks with no changes planned during the 8-week intervention phase
  • Nurses delivering the intervention must be Registered Nurses or similar medical professionals working as school nurses and fluent in English
Not Eligible

You will not qualify if you...

  • Children who do not meet the inclusion criteria for age, anxiety symptoms, or language fluency
  • Nurses who are not Registered Nurses or not working as school nurses or not fluent in English

Research Team

G

Golda S Ginsburg, Ph.D.

K

Kelly Drake, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here